Miguel Angel González, president of the Guayaquil Chamber of Commerce, has spoken out against the proposed Capital Gains Law being now discussed in the country’s National Assembly. The law, he said, “Does not meet the goal of ending speculation. We, as the Chamber of Commerce, emphatically reject the new Capital Gains Law, as we consider it to be untimely, illegitimate and unjust, implying greater negatives than positives for the country.”
The law would be untimely, he said, due to the economic slowdown affecting the country, during which time no new taxes should be approved, but rather should focus on tax incentives that could re-start the economy. “We should note that the mere fact that we are discussing this law proposal has already created mistrust, fear and uncertainty, during a difficult time for the economy.”
It would be illegitimate, González continued, because “it is not right that governments should interfere and determine what the proper level of earnings one should have. Governments should not determine profit levels. It is anti-technical to interfere with the natural dynamics of supply, demand and natural price-fixing.”
Full Content: Ecuador Inmediato
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Justice Department Moves to End NCAA Transfer Rule
May 30, 2024 by
CPI
Kenya’s Competition Authority Proposes Tougher Regulations on Big Tech
May 30, 2024 by
CPI
KKR Secures EU Antitrust Approval for $24 Billion Acquisition of Telecom Italia’s Fixed-Line Network
May 30, 2024 by
CPI
European Court Sides with Tech Giants in Italian Regulatory Dispute
May 30, 2024 by
CPI
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 31, 2024 by
CPI
AI and Antitrust Considerations in U.S. Health Care
May 31, 2024 by
CPI
Uncertainty in the Bottom Line: New Antitrust Scrutiny and Enforcement in Private Equity Transactions
May 31, 2024 by
CPI
Effecting M&A Diligence When Competitors Are Involved
May 31, 2024 by
CPI
AI, Pharmaceutical Sector, and EU Competition Law and Policy: What Does the Future Look Like?
May 31, 2024 by
CPI